Format

Send to

Choose Destination
Rev Med Inst Mex Seguro Soc. 2015 Mar-Apr;53(2):214-25.

[Clinical practice guideline. Diagnosis and treatment of postmenopausal and perinemopausia].

[Article in Spanish; Abstract available in Spanish from the publisher]

Author information

1
Asociación Mexicana para el Estudio del Climaterio, Distrito Federal, México. dra.basa06@gmail.com.

Abstract

in English, Spanish

Post-menopause is the period of life where a deep decline occurs in circulating estrogen levels, inducing the appearance of psycho and somatic symptoms. The classification to understand the chronology of reproductive aging in women (known as STRAW) determines the clinical and endocrine changes contemplating menstrual cycles, symptoms, measurements of FSH, LH, inhibin B, anti-Mullerian hormone , and follicular account. The diagnosis of menopause is established by the absence of menstruation for 12 months or more. The most frequent clinical manifestations of the climacteric syndrome transition to menopause are menstrual disorders, vasomotor symptoms (flushes and/or sweats) and genitourinary manifestations. The assessment of women in the peri- or postmenopause aims to develop: cervicovaginal cytology , lipid profile , serum glucose, basal Mammography at least a year before, pelvic ultrasound, urinalysis, serum TSH, Densitometry in patients older than 60 years if there is no recourse can be applied and FRAX. Drug therapy for the treatment of disorders of the transition to menopause or menopause is divided into: hormone therapy (HT) based estrogens and progestin hormone not being the most recommended the serotonin reuptake inhibitors and norepinephrine, clonidine, gabapentin or veralipride.

KEYWORDS:

Aging; Menopause; Postmenopausal

PMID:
25760751
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center